Global Pharmaceutical
Top 10 Pharma Reduces Deviation Triage Time by 65%
AI-powered deviation classification transformed a drowning quality team into proactive risk managers
Case Study
In Vitro Diagnostics
5,000+ employees, global operations
AI-powered vendor risk scoring turned an annual compliance exercise into continuous intelligence
Improvement Achieved
A global IVD manufacturer had 400+ third-party vendors with access to GxP systems and data. Annual security assessments were manual (vendor questionnaires, SOC 2 reviews, spreadsheet risk scoring) and took 6 weeks per vendor. By the time assessments were complete, vendor security postures had already changed. The security team had no visibility into emerging vendor risks between annual reviews. TPRM was a compliance checkbox, not real risk management.
Implemented AI-powered third-party risk management (TPRM) platform with continuous vendor monitoring. The AI agent continuously scans vendor security postures (SOC 2 expiration, breach notifications, financial health signals, regulatory actions), scores risk in real-time based on GxP system access and data sensitivity, auto-generates vendor risk dashboards, alerts security team when vendor risk scores change, and drafts vendor assessment reports with evidence-based risk recommendations.
95% reduction in assessment time — from 6 weeks to 3 days per vendor
Real-time risk dashboards replaced annual point-in-time snapshots
12 critical vendor risks identified in first month — all missed by prior manual assessments
3 high-risk vendors offboarded before security incidents occurred
Continuous monitoring now covers 400 vendors with same team that previously assessed 40 annually
We found vulnerabilities in our supply chain that manual reviews had missed for years. Continuous AI monitoring turned TPRM from a compliance burden into a strategic advantage.
— Chief Information Security Officer
See how GxP Agents can transform your in vitro diagnostics operations with AI purpose-built for regulated industries.
Book a DemoGlobal Pharmaceutical
AI-powered deviation classification transformed a drowning quality team into proactive risk managers
Emerging Biotech
AI-assisted submission assembly and regulatory intelligence turned an 18-month timeline into 15
Specialty Pharmaceutical
AI-assisted review freed QA to focus on exceptions, not paperwork — and caught errors humans missed